(Zu Ihrer Information: initiale Veröffenlichungen unter dem Namen Hergovich, danach Namensänerung erfolgt)

1) Stohlawetz P., Hergovich N., Stiegler G., Eichler HG., Hocker P., Kapiotis S., Jilma B.; Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin; Transfusion 1998; 38(1):24-30

2) Stohlawetz P., Kapiotis S., Seidl D., Hergovich N., Zellner M., Eichler HG., Stiegler G., Leitner G., Hocker P., Jilma B.;Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis and neutrophils and on the formation of neutrophil-platelet aggregates; Transfusion 1999 39(4):420-7.

3) Jilma B., Hergovich N., Stohlawetz P., Stummvoll G., Albinni S., Simak G., Schmaldienst S., Pohanka, Eichler HG., Kapiotis S.;Effects of sodium nitroprusside on hemodialysis induced platelet activation; Kidney Intern. 1999 55:686-691.

4) Jilma B., Hergovich N., Stohlawetz P., Eichler HG., Bauer P., Wagner OF; Circadian variation of granulocyte-colony stimulating factor in men; Br J Haematol 1999 106:368-370.

5) Hergovich N., Aigner M., Eichler HG, Etlicher J., Druker C., Jilma B.: Paroxetine decreases platelet serotonin storage and platelet function in human beings.; Clin Pharmacol Ther 2000 68(4):435-42.

6) Homoncik M., Jilma B., Hergovich N., Handler S., Eichler HG., Pernerstorfer T., Stohlawetz P., Janisiwi M., Panzer S., Speiser W.; Evaluation of aspirin pharmacodynamics with the platelet function analyzer PFA-100â; Thromb and Haemost 2000 83:316-21.

7) Jilma B., Dallinger S., Hergovich N., Eichler HG., Richter V., Wagner., Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules.; J Clin Endocrinol Metab 2000 85(5):1748-51.

8) Jilma-Stohlawetz P., Dzirlo L., Hergovich N., Lackner E., Mensik C., Eichler HG., Kabrna E., Geissler K., Jilma B.:Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 2000 95(9):2983-2989.

9) Jilma B., Hergovich N., Homoncik M., Kreuzer C., Stohlawetz P., Pernerstorfer T., Eichler HG., Pugin G.; Graulocyte colony stimulating factor (G-CSF) down regulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans; Br J Haematol 2000 111:314-320.

10) Hergovich N., Singer E., Agneter E., Eichler HG., Graselli U., Simhandl Ch., Jilma B.;Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men; a randomized double blind placebo-controlled trial; Neuropsychopharmacology 2001 24(5):590-3.

11) Jilma-Stohlawetz P., Hergovich N., Homoncik M., Eichler HG., Horvath M., Janisiw M., Panzer S., Jilma B. Impaired platelet function among platelet donors. Thromb and Haemost 2001 86(3):880-6.

12) Oehler R, Pusch E, Zellner M, Dungel P, Hergovich N, Homoncik M, Eliasen MM, Brabec M, Roth E. Cell type- specific variations in the induction of hsp70 in human leukocytes by feverlike whole body hyperthermia. Cell Stress Chaperones 2001 6(4):306-15.

13) Zellner M, Hergovich N, Roth E, Jilma B, Spittler A, Oehler R. Human monocyte stimulation by experimental whole body hyperthermia. Wien Klin Wochenschr 2002 114(3):102-7.

14) Jilma B, Hergovich N, Homoncik M, Marsik C, Kreuzer C, Jilma-Stohlawetz P. Rapid down modulation of P-selectin glycoprotein ligand-1 (PSGL-1, CD162) by G-CSF in humans. Transfusion 2002 42(3):328-33.

15) Kotzailias N., Finsterer J.,Pratscher B., Rauch A., Eichler HG, Jilma B. Influence of tiapride on platelet counts in healthy volunteers and patients with movement disorders: Progr Neuro-Psychopharmacol & Biol Psych 2003 27(4):595-9.

16) Kotzailias N, Müller C. Medikamentöse Sekundärprophylaxe des ischämischen Schlaganfalls. ProMed 2003,             

17) Kotzailias N., Binder T., Mueller C., Willinger B., Graninger W., Presterl E. Sucsessful treatment of Candida albicans endocarditis with caspofungin; Trends in Medical Mycology 2003 p211-16.

18) Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003 14(5):329-331.

19) Kotzailias N., Marker M., Drucker C., Eichler HG, Jilma B. Early effects of paroxetine on serotonin storage, plasma levels and urinary excretion - a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 2003 24(5):536-9.

20) Kotzailias N, Müller C. Medikamentöse Sekundärprophylaxe des ischämischen Schlaganfalls. Psycho Prax 2004

21) Kotzailias N., Finsterer J., Zellner M., Dukic T, Marsik C., Jilma B. Platelet function in mitochondriopathy with stroke and stroke-like episodes; Thrombosis and Hemostasis             2004 91(3):544-52.

22) Tribl GG., Sycha T., Kotzailias N., Zeitlhofer J., Auff E. Apomorphine in idiopathic restless legs syndrome: an exploratory study. J Neurol Neurosurg Psychiatry 2005 76(2):181-5.

23) Kotzailias N, Andonovski T, Dukic A, Serebruany VL, Jilma B.Antiplatelet activity during    coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male      smokers: a randomized, placebo-controlled, double-blind trial. J Clin Pharmacol. 2006    46(4):468-75.

24) Sycha T, Kotzailias N, Kranz G, Trautinger F, Schnider P, Auff E.UV-B irradiation attenuates   dermal effects of botulinum toxin A: a randomized, double-blind, placebo-controlled study.     Dermatol Surg. 2007 33(1 Spec No.):S92-6.

25) Kotzailias N, Elwischger K, Sycha T, Rinner W, Quehenberger P, Auff E, Müller C.Clopidogrel- induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients. J Stroke Cerebrovasc Dis. 2007 16(5):199-202.    

26) Kotzailias N, Graninger M, Knechtelsdorfer M, Jilma B.Acute effects of hyperglycaemia on     plasma concentration of soluble P-selectin and von Willebrand factor in healthy volunteers -a prospective randomised double blind controlled study. Thromb Res. 2009 123(3):452-9.      

27) Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, Baumgartner R, Attems J, Gerner C, Jellinger K, Roth E, Oehler R, Umlauf E.Comparative platelet proteome         analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's         disease but not in non-demented Parkinson's disease patients. J Proteomics. 2012    75(7):2080-92.